Goločorbin-Kon, Svetlana
Results 41-60 of 68 (Search time: 0.004 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
41 | 1-Jan-2015 | The measurement of Cefotaxime sodium in rat plasma after oral administration: A sensitive HPLC-UV method | Mosab Arafat; Svetlana Goločorbin-Kon ; Momir Mikov |
42 | 2016 | Methotrexate - an old drug with new pharmaceutical formulations and new indications | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Bojan Stanimirov ; Saša Vukmirović ; Boris Milijašević |
43 | 9-Sep-2014 | Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol | Mooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Al-Salami H. |
44 | 2-Sep-2016 | MICROVESICLE FORMULATION CONTAINING SODIUM 3 ,7 - DIHYDROXY-12- KETO-5 - CHOLANATE ENHANCES ORAL ABSORPTION OF CEFOTAXIME | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Mladena Lalić-Popović ; Boris Milijašević ; Bojan Stanimirov ; Saša Vukmirović ; Momir Mikov |
45 | 2019 | New pharmaceutical formulations and new indications for an old drug - methotrexate | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Maja Đanić ; Boris Milijašević ; Milica Paut Kusturica ; Ana Tomas Petrović ; Bojan Stanimirov ; Hani Al-Salami; Momir Mikov |
6 | 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat | Nebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov |
7 | 28-Jul-2014 | Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study | Mooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H. |
8 | 1-Jan-2015 | Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study | Mooranian A.; Negrulj R.; Momir Mikov ; Svetlana Goločorbin-Kon ; Arfuso F.; Al-Salami H. |
9 | 18-Sep-2018 | Novel nano-encapsulation of probucol in microgels: Scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses | Armin Mooranian; Nassim Zamani; Mikov, Momir ; Goločorbin-Kon, Svetlana ; Stojanović, Goran ; Frank Arfuso; Hani Al-Salami |
10 | 12-Nov-2018 | Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses | Armin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami |
11 | 18-Jul-2016 | On the optimal high dose methotrexate administration in the consolidation phase of acute lymphoblastic leukaemia in children | Dragan Spasić ; Nenad Grahovac ; Miodrag Žigić ; Jovanka Kolarović ; Svetlana Goločorbin-Kon ; Momir Mikov |
12 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
13 | 12-Nov-2018 | Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes | Mooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H. |
14 | 5-Jun-2020 | Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine Model | Armin Mooranian; Nassim Zamani; Božica Kovačević; Corina Mihaela Ionescu; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Sanja Kojić ; Hani Al-Salami |
15 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
16 | 17-Sep-2019 | Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants | Kecman, S; Škrbić R.; Alma Badnjević Čengić; Armin Mooranian; Hani Al-Salami; Momir Mikov ; Svetlana Goločorbin-Kon |
17 | 1-Jan-2014 | Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes | Mooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Lambros A.; Al-Salami H. |
18 | 1-Jan-2019 | Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice | Mooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H. |
19 | 1-Jan-2015 | Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment | Mooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Aruso F.; Al-Salami H. |
20 | 20-Sep-2016 | Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modeling | Jovana Trifunović; Vladan Borčić; Saša Vukmirović ; Svetlana Goločorbin-Kon ; Momir Mikov |